^

Health

A
A
A

Monoclonal gammopathy of undetermined character

 
, medical expert
Last reviewed: 07.07.2025
 
Fact-checked
х

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

In monoclonal gammopathy of undetermined significance, M-protein is produced by non-malignant plasma cells in the absence of other manifestations of multiple myeloma.

The incidence of monoclonal gammopathy of undetermined significance (MGUS) increases with age, from 1% in people aged 25 years to 4% in people over 70 years. MGUS may occur in combination with other diseases in which the M protein may be due to antibodies produced in large quantities in response to a prolonged antigenic stimulus.

trusted-source[ 1 ], [ 2 ], [ 3 ], [ 4 ], [ 5 ], [ 6 ], [ 7 ]

Symptoms and diagnosis of monoclonal gammopathy

Monoclonal gammopathy of undetermined significance is usually asymptomatic, but peripheral neuropathy may occur. Although most cases are benign, 25% (1% per year) progress to B-cell tumors, myeloma, or macroglobulinemia.

M-protein in blood or urine is usually detected incidentally during routine examinations. In laboratory evaluation, M-protein is detected in low concentrations in serum (< 3 g/dL) or urine (< 300 mg/24 h). Unlike other plasma cell disorders, in monoclonal gammopathy of undetermined significance, the M-protein level remains stable over time, the levels of other serum immunoglobulins are normal, and in most cases there is no bone destruction, anemia, or Bence Jones proteinuria.

Who to contact?

Treatment of monoclonal gammopathy

There is no treatment for monoclonal gammopathy of undetermined significance. Patients should be monitored every 6-12 months with clinical examination and urine protein electrophoresis.

You are reporting a typo in the following text:
Simply click the "Send typo report" button to complete the report. You can also include a comment.